Patient Access and Screening Strategies for NASH Clinical Research
Study participant identification and recruitment continue to be significant challenges in NASH clinical research, impacting cost and timelines.
Many clients utilize ProSciento’s pre-screening to identify patients with steatosis or steatohepatitis using a noninvasive methodology combining vibration controlled transient elastography (VCTE) FibroScan, proprietary clinical algorithms and metabolomic testing. The pre-screening program increases efficiencies by identifying patients that are highly probable to meet recruitment criteria prior to utilizing imaging techniques or biopsies, thereby reducing screen failure rates and avoiding unnecessary invasive and expensive procedures in the enrollment phase of NASH clinical trials.
ProSciento’s Proprietary Pre-Screening Program:
ProSciento’s patient pre-screening, summarized visually below, is a method to identify patients with NAFLD and NASH prior to imaging or biopsies. Clients may choose to utilize this program to increase enrollment efficiencies at clinical research sites.
Click each for a step-by-step description of the patient pre-screening program.